Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders

Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders

US Patent 7214673 · Granted May 8, 2007

Estimated economic value: $92,297,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

PIM1 inhibitors for use in treatment of viral infection and pharmaceutical compo2025
AT2R antagonists and uses thereof2024
7 (methylamino)pyrazolo[1,5-a]pyrimidine-3-carboxamide derivatives2024
Pyrazolo[1,5-a]pyrimidine-3-carboxamide derivatives useful in the treatment of p2024
Photonic package device and method for fabricating the same2023
Substituted pyrazolo[1,5-a]pyrimidines as inhibitors of interferon signaling2023
Methods of manufacturing semiconductor device and semiconductor device2022
Aryl dihydro-2H benzo[b][1,4]oxazine sulfonamide and related compounds for use a2021
Methods of manufacturing semiconductor device and semiconductor device2021
Flexible and stretchable electronic device based on biocompatible film and prepa2021
Self-aligned double patterning (SADP) method2020
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compo2020